Requirements to the chemical and pharmaceutical quality documentation concerning investigational medicinal products in clinical trials

  • Email
  • Help
Current effective version

First version - adopted guideline

Currently under revision - see below

Reference numberCHMP/QWP/185401/2004
Effective from01/10/2006
KeywordsClinical trial, quality
DescriptionThis document addresses the documentation on the chemical and pharmaceutical quality of investigational medicinal product dossier containing chemically defined drug substances, synthetic peptides, herbal substances, herbal preparations and chemically defined radio-active/radio-labelled substances to be submitted to the competent authority for approval prior to beginning a clinical trial in humans.

Document history

Revision 1 

In progress

Adopted guideline

Overview of comments

Draft guidelines

Concept paper

Published: 28/11/2017
Effective from: 28/05/2018

Published: 28/11/2017

Published: 12/04/2006

Published: 30/03/2015

First version

Current version

Adopted guideline

In operation: 01/10/2006–present

Related content

How helpful is this page?

Average rating:

 Based on 15 ratings

Add your rating:

See all ratings
3 ratings
3 ratings
3 ratings
3 ratings
3 ratings

Tell us more